SlideShare a Scribd company logo
MALARIA
β€’ Submitted to- Mr. Appras willas Submitted by: Rahul
Pal
INTRODUCTION
β€’ Malaria is a mosquito born-disease caused by plasmodium, which is transmitted
by the bite of infected female anopheles mosquito.
β€’ The term malaria originated from Italian word: mal’
aria – β€œbad air”.
- Malaria remains the world’s most devastating human parasitic infection.
Malaria affects over 40% of the world’s population. WHO, estimates
that there are 350-500 million cases of malaria worldwide.
- In India 2 million cases & 100 deaths annually.
HISTORY
β€’ Malaria is the associated disease have been noted 4000 years ago.
β€’ Malaria may have contributed to the decline of the Roman Empire, and was so pervasive
in Rome that it was known as the β€œRoman fever”.
β€’ Scientific studies on malaria made their first significant advance in 1880, when Charles
Louis Alphonse Laveran – a French army doctor working In the military hospital of
Constantine in Algeria – observed parasites inside the red blood cells of infected people
for the first time. For this & later discoveries, he was awarded the 1907 Noble prize for
physiology or medicines.
β€’ The first effective treatment for malaria came from the bark of cinchona tree, which
contains quinine.
SYMPTOMS OF MALARIA
β€’ Physical findings may include:
β€’ Elevated temperature.
β€’ Weakness.
β€’ Enlarged spleen.
β€’ Increased respiration rate.
OTHER SYMPTOMS:
β€’ Dry cough.
β€’ Muscle or back pain or both.
β€’ Loss of consciousness.
β€’ Infection of brain or spinal cord.
β€’ Skin may be chills & sweating.
β€’ Nausea & vomiting.
PATHOGENESIS
β€’ Incubation period:10-14 days in P.vivax, P.falciparum & P. oval but it 28-30 days in
P.malariae.
β€’ The typical clinical features consists of febrile paroxysm, anemias & splenomegaly.
STAGES OF DISEASE
β€’ Cold stage= -feeling of intense cold.
β€’ -Vigorous shivering, rigor.
β€’ - Lasts 15-60 min.
β€’ Hot stage- = Intense heat.
β€’ =Dry burning skin.
β€’ = Lasts 2-6 hours.
β€’ Sweating stage= -Profuce sweting.
β€’ - Declining temperature.
β€’ -Lasts 2-4 hours.
DIAGNOSIS
β€’ Laboratory: thin, thick smears, antigen capture & PCR etc.
β€’ Clinical : platelets.
β€’ Other tastes: CBC
β€’ Lukopenia, throbocytobenia & increase ESR.
β€’ Chest x ray- helpful if respiratory symptoms are present.
β€’ CT scan- to evaluate evidence of cerebral edema or hemorrhage.
TREATMENT
Drug:
β€’ 01). Cloroquine.
β€’ 02). Primaquine.
β€’ 03). quinine.
β€’ 04). Artemisinin.
Active Ingredient
β€’ 4-aminoquinolone.
β€’ 8-aminoquinolone.
β€’ Quinine.
β€’ Sesquiterpene lactone.
Malaria Presentation Onwards Rahul Pals.pptx
Malaria Presentation Onwards Rahul Pals.pptx

More Related Content

Similar to Malaria Presentation Onwards Rahul Pals.pptx

Typhoid fever or enteric fever
Typhoid fever or enteric feverTyphoid fever or enteric fever
Typhoid fever or enteric fever
MansiPanchal30
Β 
MALARIA AND AIDS.pptx
MALARIA AND AIDS.pptxMALARIA AND AIDS.pptx
MALARIA AND AIDS.pptx
RITIKARana18
Β 
Malaria shyam
Malaria shyamMalaria shyam
Malaria shyam
Dr Praman Kushwah
Β 
seminar on Malaria
seminar on Malaria seminar on Malaria
seminar on Malaria
Dr Praman Kushwah
Β 
Arbovirus
ArbovirusArbovirus
Arbovirus
Gladwin Jeemon
Β 
Bovine Epemeral Fever Disease: Introduction
Bovine Epemeral Fever Disease: IntroductionBovine Epemeral Fever Disease: Introduction
Bovine Epemeral Fever Disease: Introduction
Sanjeev Kumar
Β 
Malaria
MalariaMalaria
Malaria
Awaaz Batazoo
Β 
Anthrax (medicine for graduate student series)
Anthrax  (medicine for graduate student series)Anthrax  (medicine for graduate student series)
Anthrax (medicine for graduate student series)
Augustine raj
Β 
typhoid.pptx
typhoid.pptxtyphoid.pptx
typhoid.pptx
VidhiBajaniya
Β 
MALARIA.ppt
MALARIA.pptMALARIA.ppt
MALARIA.ppt
AmanuelDina1
Β 
Arthopod vector borne diseases
Arthopod vector borne diseases Arthopod vector borne diseases
Arthopod vector borne diseases
vinay nandimalla
Β 
CHEMO-IMMUNOTHERAPY FOR GLANDERS
CHEMO-IMMUNOTHERAPY FOR GLANDERSCHEMO-IMMUNOTHERAPY FOR GLANDERS
CHEMO-IMMUNOTHERAPY FOR GLANDERS
IVRI
Β 
Malaria
MalariaMalaria
Malaria
TemesgenGirma1
Β 
Malaria
MalariaMalaria
Malaria
safeer muhammed
Β 
Malaria
MalariaMalaria
Malaria
Malaria Malaria
Malaria Sudhir Dev
Β 
Malaria introduction and epidemiology.ppt
Malaria introduction and epidemiology.pptMalaria introduction and epidemiology.ppt
Malaria introduction and epidemiology.ppt
PanditRhitShrm
Β 
Vector borne diseases
Vector borne diseasesVector borne diseases
Vector borne diseases
Subhrajit Roy
Β 
Ebola final
Ebola finalEbola final
Ebola final
karishma purkayastha
Β 

Similar to Malaria Presentation Onwards Rahul Pals.pptx (20)

Typhoid fever or enteric fever
Typhoid fever or enteric feverTyphoid fever or enteric fever
Typhoid fever or enteric fever
Β 
MALARIA AND AIDS.pptx
MALARIA AND AIDS.pptxMALARIA AND AIDS.pptx
MALARIA AND AIDS.pptx
Β 
Malaria
Malaria Malaria
Malaria
Β 
Malaria shyam
Malaria shyamMalaria shyam
Malaria shyam
Β 
seminar on Malaria
seminar on Malaria seminar on Malaria
seminar on Malaria
Β 
Arbovirus
ArbovirusArbovirus
Arbovirus
Β 
Bovine Epemeral Fever Disease: Introduction
Bovine Epemeral Fever Disease: IntroductionBovine Epemeral Fever Disease: Introduction
Bovine Epemeral Fever Disease: Introduction
Β 
Malaria
MalariaMalaria
Malaria
Β 
Anthrax (medicine for graduate student series)
Anthrax  (medicine for graduate student series)Anthrax  (medicine for graduate student series)
Anthrax (medicine for graduate student series)
Β 
typhoid.pptx
typhoid.pptxtyphoid.pptx
typhoid.pptx
Β 
MALARIA.ppt
MALARIA.pptMALARIA.ppt
MALARIA.ppt
Β 
Arthopod vector borne diseases
Arthopod vector borne diseases Arthopod vector borne diseases
Arthopod vector borne diseases
Β 
CHEMO-IMMUNOTHERAPY FOR GLANDERS
CHEMO-IMMUNOTHERAPY FOR GLANDERSCHEMO-IMMUNOTHERAPY FOR GLANDERS
CHEMO-IMMUNOTHERAPY FOR GLANDERS
Β 
Malaria
MalariaMalaria
Malaria
Β 
Malaria
MalariaMalaria
Malaria
Β 
Malaria
MalariaMalaria
Malaria
Β 
Malaria
Malaria Malaria
Malaria
Β 
Malaria introduction and epidemiology.ppt
Malaria introduction and epidemiology.pptMalaria introduction and epidemiology.ppt
Malaria introduction and epidemiology.ppt
Β 
Vector borne diseases
Vector borne diseasesVector borne diseases
Vector borne diseases
Β 
Ebola final
Ebola finalEbola final
Ebola final
Β 

More from RAHUL PAL

Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdfSoftware Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
RAHUL PAL
Β 
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdfMajor Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
RAHUL PAL
Β 
Niosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfNiosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdf
RAHUL PAL
Β 
Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptx
RAHUL PAL
Β 
𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); The Curre...
𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); The Curre...𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); The Curre...
𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); The Curre...
RAHUL PAL
Β 
Thakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfThakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdf
RAHUL PAL
Β 
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
RAHUL PAL
Β 
Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...
RAHUL PAL
Β 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
RAHUL PAL
Β 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdf
RAHUL PAL
Β 
Pharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptPharmaceutical Suspension.ppt
Pharmaceutical Suspension.ppt
RAHUL PAL
Β 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
RAHUL PAL
Β 
Partition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxPartition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptx
RAHUL PAL
Β 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
RAHUL PAL
Β 
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
RAHUL PAL
Β 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
RAHUL PAL
Β 
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
RAHUL PAL
Β 
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
RAHUL PAL
Β 
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
RAHUL PAL
Β 
Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...
RAHUL PAL
Β 

More from RAHUL PAL (20)

Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdfSoftware Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
Β 
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdfMajor Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Β 
Niosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfNiosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdf
Β 
Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptx
Β 
𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); The Curre...
𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); The Curre...𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); The Curre...
𝐎𝐫𝐚π₯ 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐒𝐨𝐧𝐚π₯ π‚π¨π§πŸπžπ«πžπ§πœπž (πˆπ‘π“π„π‚ 𝟐.𝟎-πŸπŸŽπŸπŸ’); The Curre...
Β 
Thakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfThakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdf
Β 
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
Β 
Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...
Β 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
Β 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdf
Β 
Pharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptPharmaceutical Suspension.ppt
Pharmaceutical Suspension.ppt
Β 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
Β 
Partition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxPartition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptx
Β 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Β 
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
Β 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Β 
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
Β 
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Β 
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
Β 
Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...
Β 

Recently uploaded

Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
Β 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
Β 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
Β 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
Β 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
Dr. Shivangi Singh Parihar
Β 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
Wasim Ak
Β 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
Β 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
Β 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
Β 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
ArianaBusciglio
Β 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
Β 
Delivering Micro-Credentials in Technical and Vocational Education and Training
Delivering Micro-Credentials in Technical and Vocational Education and TrainingDelivering Micro-Credentials in Technical and Vocational Education and Training
Delivering Micro-Credentials in Technical and Vocational Education and Training
AG2 Design
Β 
Landownership in the Philippines under the Americans-2-pptx.pptx
Landownership in the Philippines under the Americans-2-pptx.pptxLandownership in the Philippines under the Americans-2-pptx.pptx
Landownership in the Philippines under the Americans-2-pptx.pptx
JezreelCabil2
Β 
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
RitikBhardwaj56
Β 
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Ashish Kohli
Β 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
Β 
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
NelTorrente
Β 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
amberjdewit93
Β 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
Β 
Assignment_4_ArianaBusciglio Marvel(1).docx
Assignment_4_ArianaBusciglio Marvel(1).docxAssignment_4_ArianaBusciglio Marvel(1).docx
Assignment_4_ArianaBusciglio Marvel(1).docx
ArianaBusciglio
Β 

Recently uploaded (20)

Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
Β 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Β 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Β 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
Β 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
Β 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
Β 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Β 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
Β 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
Β 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
Β 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
Β 
Delivering Micro-Credentials in Technical and Vocational Education and Training
Delivering Micro-Credentials in Technical and Vocational Education and TrainingDelivering Micro-Credentials in Technical and Vocational Education and Training
Delivering Micro-Credentials in Technical and Vocational Education and Training
Β 
Landownership in the Philippines under the Americans-2-pptx.pptx
Landownership in the Philippines under the Americans-2-pptx.pptxLandownership in the Philippines under the Americans-2-pptx.pptx
Landownership in the Philippines under the Americans-2-pptx.pptx
Β 
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
Β 
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Β 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Β 
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
MATATAG CURRICULUM: ASSESSING THE READINESS OF ELEM. PUBLIC SCHOOL TEACHERS I...
Β 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
Β 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
Β 
Assignment_4_ArianaBusciglio Marvel(1).docx
Assignment_4_ArianaBusciglio Marvel(1).docxAssignment_4_ArianaBusciglio Marvel(1).docx
Assignment_4_ArianaBusciglio Marvel(1).docx
Β 

Malaria Presentation Onwards Rahul Pals.pptx

  • 1. MALARIA β€’ Submitted to- Mr. Appras willas Submitted by: Rahul Pal
  • 2. INTRODUCTION β€’ Malaria is a mosquito born-disease caused by plasmodium, which is transmitted by the bite of infected female anopheles mosquito. β€’ The term malaria originated from Italian word: mal’ aria – β€œbad air”. - Malaria remains the world’s most devastating human parasitic infection. Malaria affects over 40% of the world’s population. WHO, estimates that there are 350-500 million cases of malaria worldwide. - In India 2 million cases & 100 deaths annually.
  • 3. HISTORY β€’ Malaria is the associated disease have been noted 4000 years ago. β€’ Malaria may have contributed to the decline of the Roman Empire, and was so pervasive in Rome that it was known as the β€œRoman fever”. β€’ Scientific studies on malaria made their first significant advance in 1880, when Charles Louis Alphonse Laveran – a French army doctor working In the military hospital of Constantine in Algeria – observed parasites inside the red blood cells of infected people for the first time. For this & later discoveries, he was awarded the 1907 Noble prize for physiology or medicines. β€’ The first effective treatment for malaria came from the bark of cinchona tree, which contains quinine.
  • 4. SYMPTOMS OF MALARIA β€’ Physical findings may include: β€’ Elevated temperature. β€’ Weakness. β€’ Enlarged spleen. β€’ Increased respiration rate.
  • 5. OTHER SYMPTOMS: β€’ Dry cough. β€’ Muscle or back pain or both. β€’ Loss of consciousness. β€’ Infection of brain or spinal cord. β€’ Skin may be chills & sweating. β€’ Nausea & vomiting.
  • 6. PATHOGENESIS β€’ Incubation period:10-14 days in P.vivax, P.falciparum & P. oval but it 28-30 days in P.malariae. β€’ The typical clinical features consists of febrile paroxysm, anemias & splenomegaly.
  • 7. STAGES OF DISEASE β€’ Cold stage= -feeling of intense cold. β€’ -Vigorous shivering, rigor. β€’ - Lasts 15-60 min. β€’ Hot stage- = Intense heat. β€’ =Dry burning skin. β€’ = Lasts 2-6 hours. β€’ Sweating stage= -Profuce sweting. β€’ - Declining temperature. β€’ -Lasts 2-4 hours.
  • 8. DIAGNOSIS β€’ Laboratory: thin, thick smears, antigen capture & PCR etc. β€’ Clinical : platelets. β€’ Other tastes: CBC β€’ Lukopenia, throbocytobenia & increase ESR. β€’ Chest x ray- helpful if respiratory symptoms are present. β€’ CT scan- to evaluate evidence of cerebral edema or hemorrhage.
  • 9. TREATMENT Drug: β€’ 01). Cloroquine. β€’ 02). Primaquine. β€’ 03). quinine. β€’ 04). Artemisinin. Active Ingredient β€’ 4-aminoquinolone. β€’ 8-aminoquinolone. β€’ Quinine. β€’ Sesquiterpene lactone.